<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1331" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1331/" /><meta name="ncbi_pagename" content="NDP-Related Retinopathies - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>NDP-Related Retinopathies - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="NDP-Related Retinopathies" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/09/18" /><meta name="citation_author" content="Katherine B Sims" /><meta name="citation_pmid" content="20301506" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1331/" /><meta name="citation_keywords" content="X-Linked Familial Exudative Vitreoretinopathy (X-linked FEVR)" /><meta name="citation_keywords" content="Coats Disease" /><meta name="citation_keywords" content="Norrie Disease (ND)" /><meta name="citation_keywords" content="Persistent Hyperplastic Primary Vitreous (PHPV)" /><meta name="citation_keywords" content="NDP-Related Retinopathy of Prematurity (ROP)" /><meta name="citation_keywords" content="Norrin" /><meta name="citation_keywords" content="NDP" /><meta name="citation_keywords" content="NDP-Related Retinopathies" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="NDP-Related Retinopathies" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Katherine B Sims" /><meta name="DC.Date" content="2014/09/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1331/" /><meta name="description" content="NDP-related retinopathies are characterized by a spectrum of fibrous and vascular changes of the retina at birth that progress through childhood or adolescence to cause varying degrees of visual impairment. The most severe phenotype is described as Norrie disease (ND), characterized by grayish-yellow fibrovascular masses (pseudogliomas) secondary to retinal vascular dysgenesis and detachment. Congenital blindness is almost always present. Approximately 30%-50% of males with ND have developmental delay / intellectual disability, behavioral abnormalities, or psychotic-like features. The majority of males with ND develop sensorineural hearing loss. Less severe phenotypes include: persistent hyperplastic primary vitreous (PHPV), characterized by a fibrotic white stalk from the optic disk to the lens; X-linked familial exudative vitreoretinopathy (XL-FEVR), characterized by peripheral retinal vascular anomalies with or without fibrotic changes and retinal detachment; retinopathy of prematurity (ROP); and Coats disease, an exudative proliferative vasculopathy. Phenotypes can vary within families." /><meta name="og:title" content="NDP-Related Retinopathies" /><meta name="og:type" content="book" /><meta name="og:description" content="NDP-related retinopathies are characterized by a spectrum of fibrous and vascular changes of the retina at birth that progress through childhood or adolescence to cause varying degrees of visual impairment. The most severe phenotype is described as Norrie disease (ND), characterized by grayish-yellow fibrovascular masses (pseudogliomas) secondary to retinal vascular dysgenesis and detachment. Congenital blindness is almost always present. Approximately 30%-50% of males with ND have developmental delay / intellectual disability, behavioral abnormalities, or psychotic-like features. The majority of males with ND develop sensorineural hearing loss. Less severe phenotypes include: persistent hyperplastic primary vitreous (PHPV), characterized by a fibrotic white stalk from the optic disk to the lens; X-linked familial exudative vitreoretinopathy (XL-FEVR), characterized by peripheral retinal vascular anomalies with or without fibrotic changes and retinal detachment; retinopathy of prematurity (ROP); and Coats disease, an exudative proliferative vasculopathy. Phenotypes can vary within families." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1331/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/norrie/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1331/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CFC25E04138D100000000028A00EC.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1331_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1331_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/myotonic-d2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/nfia-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1331_"><span class="title" itemprop="name"><i>NDP</i>-Related Retinopathies</span></h1><p class="contrib-group"><span itemprop="author">Katherine B Sims</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1331_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1331_ai__"><div class="contrib half_rhythm"><span itemprop="author">Katherine B Sims</span>, MD<div class="affiliation small">Director, Developmental Neurogenetics Clinic<br />Director, Neurogenetics DNA Diagnostic Lab<br />Professor, Neurology<br />Massachusetts General Hospital / Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.hgm@smisk" class="oemail">ude.dravrah.hgm@smisk</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 30, 1999</span>; Last Update: <span itemprop="dateModified">September 18, 2014</span>.</p><p><em>Estimated reading time: 28 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="norrie.Summary" itemprop="description"><h2 id="_norrie_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>NDP</i>-related retinopathies are characterized by a spectrum of fibrous and vascular changes of the retina at birth that progress through childhood or adolescence to cause varying degrees of visual impairment. The most severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is described as Norrie disease (ND), characterized by grayish-yellow fibrovascular masses (pseudogliomas) secondary to retinal vascular dysgenesis and detachment. Congenital blindness is almost always present. Approximately 30%-50% of males with ND have developmental delay / intellectual disability, behavioral abnormalities, or psychotic-like features. The majority of males with ND develop sensorineural hearing loss. Less severe phenotypes include: persistent hyperplastic primary vitreous (PHPV), characterized by a fibrotic white stalk from the optic disk to the lens; <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (XL-FEVR), characterized by peripheral retinal vascular anomalies with or without fibrotic changes and retinal detachment; retinopathy of prematurity (ROP); and Coats disease, an exudative proliferative vasculopathy. Phenotypes can vary within families.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>NDP</i>-related retinopathies relies on a combination of clinical findings and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>NDP</i>, which identifies pathogenic variants in approximately 95% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment for less than complete retinal detachment includes surgery and/or laser therapy with the potential for improved outcomes if done at an early age. Surgery may be required for increased intraocular pressure. Rarely, enucleation of the eye is required to control pain. Treatment for hearing loss may include hearing aids and cochlear implantation. Behavioral issues and/or cognitive impairment involve supportive intervention and therapy.</p><p><i>Surveillance:</i> Routine monitoring of vision and hearing.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>NDP</i>-related retinopathies are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Affected males transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all their daughters, who will be carriers, and none of their sons. Carrier females have a 50% chance of transmitting the pathogenic variant to each child; males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, and females who inherit the pathogenic variant will be carriers and will generally not be affected. Carrier testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant has been identified in the family.</p></div></div><div id="norrie.GeneReview_Scope"><h2 id="_norrie_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="norrie.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1331/table/norrie.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__norrie.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_norrie.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>NDP</i>-Related Retinopathies: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_norrie.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Norrie disease (ND)</div></li><li class="half_rhythm"><div>Persistent hyperplastic primary vitreous (PHPV)</div></li><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (X-linked FEVR)</div></li><li class="half_rhythm"><div><i>NDP</i>-related retinopathy of prematurity (ROP)</div></li><li class="half_rhythm"><div>Coats disease</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#norrie.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="norrie.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#norrie.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="norrie.Diagnosis"><h2 id="_norrie_Diagnosis_">Diagnosis</h2><div id="norrie.Suggestive_Findings"><h3>Suggestive Findings</h3><p>An <i>NDP</i>-related retinopathy should be suspected in individuals with the following ocular findings:</p><ul><li class="half_rhythm"><div>Congenital visual failure / blindness</div></li><li class="half_rhythm"><div>Bilateral, often symmetric involvement of the eyes</div></li><li class="half_rhythm"><div>Persistent hyperplastic primary vitreous, hyaloid vessels, shallow anterior chamber, and vitreoretinal hemorrhages. Microopthalmia and cataracts may be present.</div></li><li class="half_rhythm"><div>Presence of retrolental fibrous and vascular retinal changes at birth (leukokoria) with progressive changes through childhood or adolescence</div></li></ul><p>Pathogenic variants in <i>NDP</i> are associated with a spectrum of characterized retinal findings ranging from classic Norrie disease (ND) to <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (FEVR), some cases of persistent hyperplastic primary vitreous (PHPV), Coats disease, and advanced retinopathy of prematurity (ROP). These phenotypes appear to be a continuum of retinal findings with considerable overlap (<a class="figpopup" href="/books/NBK1331/table/norrie.T.classification_of_ocular_phenot/?report=objectonly" target="object" rid-figpopup="fignorrieTclassificationofocularphenot" rid-ob="figobnorrieTclassificationofocularphenot">Table 1</a>).</p><div id="norrie.T.classification_of_ocular_phenot" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Classification of Ocular Phenotypes Observed in Individuals with an <i>NDP</i> Pathogenic Variant</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1331/table/norrie.T.classification_of_ocular_phenot/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__norrie.T.classification_of_ocular_phenot_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ocular Findings /<br />Age</th><th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progression /<br />Age</th><th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vision</th></tr></thead><tbody><tr><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Norrie disease (ND)</b></td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Grayish-yellow fibrovascular masses (a "pseudoglioma") behind the lens (i.e., retrolental), retinal detachment (frequent) /<br />Birth &#x02013; 3 mos</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cataract, posterior synechiae (iris to lens), anterior synechiae (iris to cornea), iris atrophy, shallowing of anterior chamber, corneal opacification, bandkeratopathy, loss of intraocular pressure, shrinking of the globe (phthisis bulbi) /<br />3 mos to 8-10 yrs</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Light perception impaired or non-existent</td></tr><tr><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Persistent hyperplastic primary vitreous (PHPV)&#x000a0;<sup>1</sup></b></td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fibrotic white stalk w/hyaloid vessels extending from optic disk to posterior lens capsule /<br />Birth</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown /<br />Unknown</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Varying impairment</td></tr><tr><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (FEVR)&#x000a0;<sup>2</sup></b></td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Peripheral temporal retinal avascular zone &#x000b1; <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> retinal folds, macular ectopia, fibrous tissue band at ora serrate /<br />Birth</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Retinal detachment (tractional &#x00026;/or exudative; may be unilateral) /<br />&#x02264;20 yrs</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to impaired</td></tr><tr><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Retinopathy of prematurity (ROP) stage 4B/5&#x000a0;<sup>3</sup></b></td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Retinal neovascularization, fibrous proliferation, end-stage retrolental fibroplasia /<br />Premature birth</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Partial or complete retinal detachment</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired to blind</td></tr><tr><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Coats disease&#x000a0;<sup>4</sup></b></td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unilateral retinal telangiectasia, exudative fibrosis</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive vascular leakage, subretinal exudation &#x00026; fibrosis, retinal detachment</td><td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to impaired</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="norrie.TF.1.1"><p class="no_margin"><i>NDP</i> pathogenic variants in PHPV [<a class="bk_pop" href="#norrie.REF.shastry.2009a.884">Shastry 2009a</a>]</p></div></dd><dt>2. </dt><dd><div id="norrie.TF.1.2"><p class="no_margin"><i>NDP</i> pathogenic variants not infrequent in clinically identified <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> FEVR [<a class="bk_pop" href="#norrie.REF.nikopoulos.2010a.240">Nikopoulos et al 2010a</a>, <a class="bk_pop" href="#norrie.REF.nikopoulos.2010b.656">Nikopoulos et al 2010b</a>, <a class="bk_pop" href="#norrie.REF.poulter.2010.248">Poulter et al 2010</a>, <a class="bk_pop" href="#norrie.REF.walsh.2011.819">Walsh et al 2011</a>, <a class="bk_pop" href="#norrie.REF.yang.2012.726">Yang et al 2012</a>]</p></div></dd><dt>3. </dt><dd><div id="norrie.TF.1.3"><p class="no_margin">Rare <i>NDP</i> pathogenic variants have been seen in those with an ROP <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#norrie.REF.shastry.1997.651">Shastry et al 1997</a>]. Subsequent studies have identified DNA changes outside of the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> that may be polymorphisms and/or possible modifiers of <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression [<a class="bk_pop" href="#norrie.REF.kenyon.1999.181">Kenyon &#x00026; Craig 1999</a>, <a class="bk_pop" href="#norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</a>, <a class="bk_pop" href="#norrie.REF.talks.2001.e46">Talks et al 2001</a>, <a class="bk_pop" href="#norrie.REF.haider.2002.365">Haider et al 2002</a>, <a class="bk_pop" href="#norrie.REF.hutcheson.2005.501">Hutcheson et al 2005</a>, <a class="bk_pop" href="#norrie.REF.shastry.2009b.3">Shastry 2009b</a>].</p></div></dd><dt>4. </dt><dd><div id="norrie.TF.1.4"><p class="no_margin">In a family with an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, a female <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> had a mosaic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (Coats disease), and her sons had classic ocular findings of ND [<a class="bk_pop" href="#norrie.REF.black.1999.2031">Black et al 1999</a>].</p></div></dd></dl></div></div></div></div><div id="norrie.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of an <i>NDP</i>-related retinopathy is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>NDP</i> (see <a class="figpopup" href="/books/NBK1331/table/norrie.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="fignorrieTmoleculargenetictestingused" rid-ob="figobnorrieTmoleculargenetictestingused">Table 2</a>).</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>One genetic testing strategy</b> is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>NDP</i>. Sequence analysis is performed first and followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>An alternative genetic testing strategy</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>NDP</i> and other genes of interest (see <a href="#norrie.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p><b>Linkage analysis.</b> In the very infrequent cases where a known <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not identified, linkage analysis can be considered in families with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Linkage studies are based on accurate clinical diagnosis of <i>NDP</i>-related retinopathies in the affected family members and accurate understanding of the genetic relationships in the family. Linkage analysis is dependent on the availability and willingness of family members to be tested. The markers used for <i>NDP</i> linkage are highly informative and very tightly linked to the <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>; thus, they can be used in many families with <i>NDP</i>-related retinopathies with greater than 95% accuracy. In informative families, linkage analysis can be used to determine the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of an at-risk female.</p><div id="norrie.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>NDP</i>-Related Retinopathies</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1331/table/norrie.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__norrie.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr><tr><th headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_norrie.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Affected Males</th><th headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_norrie.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carrier Females</th></tr></thead><tbody><tr><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDP</i></td><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3 hd_h_norrie.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3 hd_h_norrie.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3 hd_h_norrie.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%&#x000a0;<sup>7</sup></td><td headers="hd_h_norrie.T.molecular_genetic_testing_used_1_1_1_3 hd_h_norrie.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="norrie.TF.2.1"><p class="no_margin">See <a href="/books/NBK1331/#norrie.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#norrie.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="norrie.TF.2.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="norrie.TF.2.3"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation may require additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>4. </dt><dd><div id="norrie.TF.2.4"><p class="no_margin">Includes the 15% of pathogenic variants that are submicroscopic deletions involving all or part of <i>NDP</i> and adjacent <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> segments [<a class="bk_pop" href="#norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</a>; Sims, unpublished]</p></div></dd><dt>5. </dt><dd><div id="norrie.TF.2.5"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd><dt>6. </dt><dd><div id="norrie.TF.2.6"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>7. </dt><dd><div id="norrie.TF.2.7"><p class="no_margin">Submicroscopic deletions involving all or part of <i>NDP</i> and adjacent <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> segments [<a class="bk_pop" href="#norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</a>; Sims, unpublished].</p></div></dd></dl></div></div></div></div></div><div id="norrie.Clinical_Characteristics"><h2 id="_norrie_Clinical_Characteristics_">Clinical Characteristics</h2><div id="norrie.Clinical_Description"><h3>Clinical Description</h3><p>The ocular findings in males with an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are usually bilateral and symmetric. They are present at birth and are usually progressive. The classic ND <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> after which the disorder is named was the first described eye finding and is the best characterized of the ocular manifestations. With the discovery of <i>NDP</i> and the advent of clinically available <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, it has become evident that the ocular phenotypes observed in <i>NDP</i>-related retinopathies include Norrie disease (ND), persistent hyperplastic primary vitreous (PHPV), and <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (XL-FEVR), [<a class="bk_pop" href="#norrie.REF.riveiroalvarez.2005.705">Riveiro-Alvarez et al 2005</a>, <a class="bk_pop" href="#norrie.REF.dickinson.2006.682">Dickinson et al 2006</a>, <a class="bk_pop" href="#norrie.REF.kondo.2007.1276">Kondo et al 2007</a>] (<a class="figpopup" href="/books/NBK1331/table/norrie.T.classification_of_ocular_phenot/?report=objectonly" target="object" rid-figpopup="fignorrieTclassificationofocularphenot" rid-ob="figobnorrieTclassificationofocularphenot">Table 1</a>).</p><p>The ocular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can vary even within a family [<a class="bk_pop" href="#norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</a>, <a class="bk_pop" href="#norrie.REF.allen.2006.234">Allen et al 2006</a>]. In one family, the spectrum of ocular phenotypes in nine <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males ranged from unilateral subtotal retinal detachment at ages three to four years that slowly progressed to a tractional detachment (at the severe end) to peripheral retinal pigmentary changes in a male age 79 years (at the mild end) [<a class="bk_pop" href="#norrie.REF.allen.2006.234">Allen et al 2006</a>].</p><p><b>Norrie disease</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Ocular findings.</b> At birth, the irises, anterior chambers, cornea, intraocular pressure, and size of the globe may be normal. In newborns and infants, the classic finding is a grayish-yellow, glistening, elevated mass that replaces the retina and is visible through a clear lens. These masses are referred to as "pseudogliomas" because they resemble tumors. Partial or complete retinal detachment evolves over the first few months.</div><div class="half_rhythm">From infancy throughout childhood, progressive changes typically include: opacification of the lens (cataract), atrophy of the iris with adhesions forming between the lens and the iris (posterior synechiae) and between the iris and the cornea (anterior synechiae), and development of a shallow anterior chamber with occlusion of the outflow tracts, which may result in increased intraocular pressure and pain.</div><div class="half_rhythm">These changes are followed by corneal opacification and band keratopathy, loss of intraocular pressure, and shrinkage of the globe (phthisis bulbi). In the end stage of ND, the corneas appear milky and opacified, and the globes appear small and sunken in the orbits [<a class="bk_pop" href="#norrie.REF.drenser.2007.243">Drenser et al 2007</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Cognitive/behavioral findings.</b> Approximately 30%-50% of males with the ND <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have developmental delay / intellectual disability and may show poorly characterized behavioral abnormalities or psychotic-like features. Intra- and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> in the appearance and expression of the cognitive and behavioral difficulties is common. A severe neurologic phenotype including infantile spasms has been reported [<a class="bk_pop" href="#norrie.REF.lev.2007.921">Lev et al 2007</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Auditory findings.</b> The majority of males with the ND <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> develop progressive sensorineural hearing loss starting in early childhood (<a class="figpopup" href="/books/NBK1331/figure/norrie.F1/?report=objectonly" target="object" rid-figpopup="fignorrieF1" rid-ob="figobnorrieF1">Figure 1</a>). Onset of hearing loss can be insidious.</div><div class="half_rhythm">Audiologic data suggest that the pathology resides in the cochlea (specifically, the stria vascularis) and that retrocochlear and brain auditory system function is normal. Early hearing loss is sensorineural, mild, and asymmetric. High-frequency hearing loss appears by adolescence. By age 35 years, hearing loss is severe, symmetric, and broad-spectrum. Speech discrimination is relatively well preserved even when the threshold loss is severe [<a class="bk_pop" href="#norrie.REF.halpin.2005.533">Halpin et al 2005</a>, <a class="bk_pop" href="#norrie.REF.halpin.2008.1705">Halpin &#x00026; Sims 2008</a>].</div><div class="half_rhythm">For most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, adaptation to the <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> blindness may be less problematic than adjustment to the later-onset, slowly progressive hearing loss.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Other.</b> Peripheral vascular disease (<a class="figpopup" href="/books/NBK1331/figure/norrie.F2/?report=objectonly" target="object" rid-figpopup="fignorrieF2" rid-ob="figobnorrieF2">Figure 2</a>) appears to be an associated clinical finding in a number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [<a class="bk_pop" href="#norrie.REF.smith.2012.1909">Smith et al 2012</a>].</div><div class="half_rhythm">Pulmonary hypertension has been described.</div><div class="half_rhythm">General health is normal. Life span may be shortened by general risks associated with intellectual disability, blindness, and/or hearing loss, such as increased risk of trauma, aspiration pneumonia, and complications of seizure disorder.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="fignorrieF1" co-legend-rid="figlgndnorrieF1"><a href="/books/NBK1331/figure/norrie.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="fignorrieF1" rid-ob="figobnorrieF1"><img class="small-thumb" src="/books/NBK1331/bin/norrie-Image001.gif" src-large="/books/NBK1331/bin/norrie-Image001.jpg" alt="Figure 1. . Hearing loss in males with Norrie disease." /></a><div class="icnblk_cntnt" id="figlgndnorrieF1"><h4 id="norrie.F1"><a href="/books/NBK1331/figure/norrie.F1/?report=objectonly" target="object" rid-ob="figobnorrieF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Hearing loss in males with Norrie disease. A subset of males enrolled in the Norrie Disease Registry (n=56) by age group with hearing loss [Smith et al 2012] </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="fignorrieF2" co-legend-rid="figlgndnorrieF2"><a href="/books/NBK1331/figure/norrie.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="fignorrieF2" rid-ob="figobnorrieF2"><img class="small-thumb" src="/books/NBK1331/bin/norrie-Image002.gif" src-large="/books/NBK1331/bin/norrie-Image002.jpg" alt="Figure 2. . Peripheral vascular disease in males with Norrie disease." /></a><div class="icnblk_cntnt" id="figlgndnorrieF2"><h4 id="norrie.F2"><a href="/books/NBK1331/figure/norrie.F2/?report=objectonly" target="object" rid-ob="figobnorrieF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Peripheral vascular disease in males with Norrie disease. Peripheral vascular disease by age group in a subset of patients enrolled in the Norrie Disease Registry (n=56) [Smith et al 2012] </p></div></div><p><b>PHPV</b> is characterized by a fibrotic white stalk with vessels extending from the optic disk to the temporal posterior lens capsule. The retina may be in folds or detached; the lens may or may not be clear. Although progression to complete retinal detachment has been described, it is not clear if such progression always occurs [<a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>]. PHPV is usually unilateral; therefore, bilateral presentation should suggest an <i>NDP</i>-related retinopathy.</p><p><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> FEVR</b> is characterized by premature arrest of vascularization of the retina resulting in an avascular zone in the peripheral retina. This avascular zone may be the only retinal finding, or <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> falciform retinal folds or retinal detachment may be present. When falciform folds are present, the macula may be dragged temporally (so-called macular ectopia).</p><p>These eye findings may progress to retinal detachment either through increasing traction on the retina from progressive fibrovascular changes in the temporal retinal periphery or through exudation of serous fluid by the fragile capillaries in the abnormal peripheral retinal vasculature. Retinal detachment is usually accompanied by a decrease in central visual acuity because of macular involvement.</p><p><b>Advanced retinopathy of prematurity</b>
<b>(ROP; Stage 4B/5)</b> involves retinal changes similar to those found in FEVR. Pathogenic variants in <i>NDP</i> were identified in four of 16 premature infants with advanced ROP [<a class="bk_pop" href="#norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</a>], raising the question of whether <i>NDP</i> pathogenic variants may predispose to the ND ocular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in some premature infants. More recently in 17 infants with advanced ROP, one was identified with an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the 5'UTR [<a class="bk_pop" href="#norrie.REF.hiraoka.2010.2572">Hiraoka et al 2010</a>]. A study of 102 Kuwaiti Arab premature infants, however, identified only polymorphisms and no phenotype-associated <i>NDP</i> pathogenic variants [<a class="bk_pop" href="#norrie.REF.haider.2001.120">Haider et al 2001</a>]. <a class="bk_pop" href="#norrie.REF.hutcheson.2005.501">Hutcheson et al [2005]</a> studied 54 infants with severe ROP (Stage &#x02265;3) of different ethnic backgrounds and identified five sequence variations in untranslated regions (UTR) of <i>NDP</i>. No clear role for these <i>NDP</i> polymorphisms in the pathogenesis of ROP was established.</p><p><b>Coats disease</b> (exudative retinitis) is an exudative proliferative vasculopathy with onset typically before age 20 years, and usually in infancy or childhood. Male-to-female ratio is 10:1. Retinal vascular changes include telangiectasias, venous and capillary fusiform dilatation, and microaneurysms. Subretinal lipid exudate and retinal hemorrhage are observed, usually in the macula and/or supertemporal regions. Exudative retinal detachment and decreased retinal capillary perfusion may occur. Other complications can include iridocyclitis, cataract, or neovascular glaucoma. More than 90% of reported cases appear to be unilateral.</p><div id="norrie.Histopathology"><h4>Histopathology</h4><p>A retinal vasculopathy appears to be the primary pathophysiologic ocular change underlying the secondary, fibrotic reaction and associated vitreous hemorrhage. Retinal ganglion cell loss may also occur.</p><p>Abnormalities of retinal vasculature have been described in the mouse model [<a class="bk_pop" href="#norrie.REF.richter.1998.2450">Richter et al 1998</a>, <a class="bk_pop" href="#norrie.REF.sch_fer.2009.906">Sch&#x000e4;fer et al 2009</a>]. In the ND mouse model, <a class="bk_pop" href="#norrie.REF.rehm.2002.4286">Rehm et al [2002]</a> documented a progressive loss of vessels in the stria vascularis of the cochlea and an associated hearing loss. A differential <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression study has identified candidate genes for retinal (photoreceptor) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the <i>Ndp</i> knockout mouse [<a class="bk_pop" href="#norrie.REF.lenzner.2002.2825">Lenzner et al 2002</a>]. Cerebellar vascular changes have also been documented in the <i>Ndph</i> knockout mouse [<a class="bk_pop" href="#norrie.REF.luhmann.2008.2619">Luhmann et al 2008</a>].</p></div><div id="norrie.Heterozygotes"><h4>Heterozygotes</h4><p>In rare instances, females who are carriers may have retinal findings (retinal detachment, abnormal retinal vasculature) [<a class="bk_pop" href="#norrie.REF.lin.2010.93">Lin et al 2010</a>, <a class="bk_pop" href="#norrie.REF.parzefall.2014.203">Parzefall et al 2014</a>] and have been described with associated vision loss [<a class="bk_pop" href="#norrie.REF.yamada.2001.52">Yamada et al 2001</a>]. A severe ocular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been described in multiple females in one family [<a class="bk_pop" href="#norrie.REF.khan.2008.730">Khan et al 2008</a>].</p><p>Some <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females may show a mild sensorineural hearing loss [<a class="bk_pop" href="#norrie.REF.halpin.2005.533">Halpin et al 2005</a>; Sims, unpublished data].</p><p>Phenotypic expression has been reported in two females with an X;autosome <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> [<a class="bk_pop" href="#norrie.REF.meire.1998.203">Meire et al 1998</a>]; however, <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> expression is usually presumed to be secondary to non-random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> and is rare.</p></div></div><div id="norrie.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Phenotypic variability, both intra- and interfamilial, has been noted in retinal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>] and in the non-retinal clinical characteristics [<a class="bk_pop" href="#norrie.REF.khan.2004.361">Khan et al 2004</a>, <a class="bk_pop" href="#norrie.REF.allen.2006.234">Allen et al 2006</a>]. Intellectual disability can be variably expressed as was noted in one of two brothers with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving the <i>NDP</i> start codon [<a class="bk_pop" href="#norrie.REF.zhang.2013.739">Zhang et al 2013</a>], although in other reported cases, multiple brothers evidenced classic <i>NDP</i> retinal features and all had intellectual disability [<a class="bk_pop" href="#norrie.REF.arai.2014.448">Arai et al 2014</a>]. A more extended phenotype including cerebellar atrophy, movement disorder, and intellectual disability was described in three brothers and supports the hypothesis that other epigenetic factors beyond the <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may affect clinical phenotypic expression [<a class="bk_pop" href="#norrie.REF.liu.2010.2653">Liu et al 2010</a>].</p><p>Males with <i>NDP</i> deletions exhibit a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than those with non-<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> pathogenic variants [<a class="bk_pop" href="#norrie.REF.su_rezmerino.2001.523">Su&#x000e1;rez-Merino et al 2001</a>, <a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>, <a class="bk_pop" href="#norrie.REF.yang.2012.726">Yang et al 2012</a>, <a class="bk_pop" href="#norrie.REF.arai.2014.448">Arai et al 2014</a>]. In addition to the ocular manifestations of ND, individuals with a deletion may have microcephaly, severe-to-profound intellectual disability, seizures, myoclonus, somatic growth failure, and/or delayed puberty.</p><p>Pathogenic variants disrupting the cysteine-knot motif appear to correspond to severe retinal dysgenesis [<a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>]. Unique single-nucleotide variants, identified in four individuals with severe retinal dysplasia, affected a cysteine residue and presumably altered important structural aspects of the protein [<a class="bk_pop" href="#norrie.REF.drenser.2007.243">Drenser et al 2007</a>].</p><p>Although it has been suggested that pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the C-terminus region may be associated with the milder FEVR <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#norrie.REF.allen.2006.234">Allen et al 2006</a>], a number of individuals with severe ocular phenotypes with or without intellectual disability have had pathogenic variants in the C-terminus region [Sims, unpublished].</p><p>No specific correlations have been identified between single-base-pair pathogenic variants and cognitive dysfunction or hearing impairment. However, one individual with a single nucleotide variant (c.134T&#x0003e;A) has been reported with a severe neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> including profound intellectual disability and infantile spasms [<a class="bk_pop" href="#norrie.REF.lev.2007.921">Lev et al 2007</a>].</p><p>Contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> syndromes with more extended and variable phenotypes have been described with <i>NDP</i>+ <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> cases [<a class="bk_pop" href="#norrie.REF.sims.1989.1069">Sims et al 1989</a>, <a class="bk_pop" href="#norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga et al 2007</a>]. Familial <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> pulmonary hypertension was reported in a family with a Xp11.3-11.4 microdeletion including <i>NDP</i> [<a class="bk_pop" href="#norrie.REF.staropoli.2010.786">Staropoli et al 2010</a>].</p><p>A more extended <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son (cerebroretinal microangiopathy with calcifications and cysts) of a mother diagnosed with unilateral atypical Coats disease was described in association with an <i>NDP</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant and <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants in <i>CTCI</i> (conserved telomere maintenance component 1) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#norrie.REF.romaniello.2013.1702">Romaniello et al 2013</a>] previously associated with a small-vessel obliterative microangiopathy in Coats plus [<a class="bk_pop" href="#norrie.REF.anderson.2012.338">Anderson et al 2012</a>] and in cerebroretinal microangiopathy with calcifications [<a class="bk_pop" href="#norrie.REF.polvi.2012.540">Polvi et al 2012</a>]. This importantly raises the question of possible pathway interactions between these two genes leading to a severe and extended phenotype both in male probands and in <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> mothers.</p></div><div id="norrie.Penetrance"><h3>Penetrance</h3><p>Penetrance is complete in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males.</p><p>Rarely, a partial or mild ocular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> occurs in <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females, presumably secondary to non-random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</p></div><div id="norrie.Nomenclature"><h3>Nomenclature</h3><p>The following are outdated terms for Norrie disease:</p><ul><li class="half_rhythm"><div>Atrophia bulborum hereditaria</div></li><li class="half_rhythm"><div>Pseudoglioma</div></li><li class="half_rhythm"><div>Episkopi blindness</div></li></ul></div><div id="norrie.Prevalence"><h3>Prevalence</h3><p>No incidence or prevalence figures are available. <i>NDP</i> pathogenic variants were identified in 11/109 individuals with diverse pediatric vitroretinopathies [<a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>].</p><p>Norrie disease has been reported in all ethnic groups, including northern and central European, Americans of European descent, African American, French-Canadian, Hispanic, Chinese, and Japanese. Although no ethnic group appears to predominate, most of the individuals reported in the first decades after the original description of Norrie disease were from Scandinavia.</p></div></div><div id="norrie.Genetically_Related_Allelic_Disor"><h2 id="_norrie_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are associated with mutation of <i>NDP</i>; however, an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cosegregating with an <i>RS</i> pathogenic variant has been identified in one family with <a href="/books/n/gene/retinoschisis/">X-linked juvenile retinoschisis</a> [<a class="bk_pop" href="#norrie.REF.hiraoka.2001b.53">Hiraoka et al 2001b</a>] but not in other retinoschisis cases, either <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> or non-familial [<a class="bk_pop" href="#norrie.REF.shastry.2000.627">Shastry et al 2000</a>].</p></div><div id="norrie.Differential_Diagnosis"><h2 id="_norrie_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/retinoblastoma/">Retinoblastoma</a> (RB) is often considered in index cases of Norrie disease (ND) if the ocular pathology is predominantly that of unilateral pseudoglioma. Because the usual presentation of ND is bilateral, diagnosis of RB is not usually a consideration. Fundoscopic examination by an ophthalmologist familiar with retinal diseases can distinguish between the two disorders.</p><p>Retinal findings of ND can mimic PHPV and retinopathy of prematurity (ROP) (which occurs in preterm low birth-weight infants who have been treated with supplemental oxygen) [<a class="bk_pop" href="#norrie.REF.shastry.2009a.884">Shastry 2009a</a>].</p><p>Autosomal dominant <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> exudative vitreoretinopathy (adFEVR) is another consideration. <i>NDP</i> is a frizzled-4 (Fzd-4) ligand and activates the canonical Wnt signaling pathway [<a class="bk_pop" href="#norrie.REF.xu.2004.883">Xu et al 2004</a>, <a class="bk_pop" href="#norrie.REF.hendrickx.2008.229">Hendrickx &#x00026; Leyns 2008</a>]. Pathogenic variants in <i>FZD4</i> [<a class="bk_pop" href="#norrie.REF.robitaille.2002.326">Robitaille et al 2002</a>], <i>LRP5</i> [<a class="bk_pop" href="#norrie.REF.jiao.2004.878">Jiao et al 2004</a>, <a class="bk_pop" href="#norrie.REF.toomes.2004.721">Toomes et al 2004</a>], and <i>TSPAN12</i> [<a class="bk_pop" href="#norrie.REF.nikopoulos.2010b.656">Nikopoulos et al 2010b</a>, <a class="bk_pop" href="#norrie.REF.poulter.2010.248">Poulter et al 2010</a>, <a class="bk_pop" href="#norrie.REF.yang.2011.1128">Yang et al 2011</a>] have been identified in <a href="/books/n/gene/fevr/">autosomal dominant FEVR</a>. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of FEVR may overlap with that of ND, <i>FZD4</i>, <i>LRP5</i>, and <i>TSPAN12</i> pathogenic variants may underlie some instances of ND in which the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> is not clear.</p><p>Retinal dysplasia with PHPV-type changes can be associated with lissencephaly in Walker-Warburg syndrome, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy, and with multiple anomalies in trisomy 13. However, neither of these should be confused clinically with Norrie disease.</p><p>ND is not considered in the differential diagnosis of intellectual disability and/or progressive sensorineural hearing loss (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>) in the absence of the characteristic ocular features.</p></div><div id="norrie.Management"><h2 id="_norrie_Management_">Management</h2><div id="norrie.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>NDP</i>-related retinopathies, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete ophthalmologic examination</div></li><li class="half_rhythm"><div>Baseline audiologic evaluation</div></li><li class="half_rhythm"><div>Neurodevelopmental assessment in early childhood if developmental milestones are not met</div></li><li class="half_rhythm"><div>Behavioral evaluation as needed</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="norrie.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Ocular manifestations</b></p><ul><li class="half_rhythm"><div>The majority of males with the classic Norrie disease (ND) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have complete retinal detachment at the time of birth; therefore, interventional therapy may not offer much with regard to preservation of sight. Ophthalmologic evaluation is warranted.</div></li><li class="half_rhythm"><div>Individuals without complete retinal detachment may benefit from surgery and/or laser therapy with the potential for improved outcomes if done at an early age.</div><ul><li class="half_rhythm"><div>A report by <a class="bk_pop" href="#norrie.REF.chow.2010.2402">Chow et al [2010]</a> described successful laser photocoagulation at birth (37 weeks' gestation) of a male with ND in which Teller visual acuity was measured at 20/100 O.D. at 23 months of life.</div></li><li class="half_rhythm"><div>Retrospective medical record review of all patients seen in a tertiary care pediatric retinal clinical practice (1988-2008) of 14 males with ND documented maintenance of light perception in at least one eye (7/14 cases) with early vitrectomy done by age 12 months (median 4.5 months) [<a class="bk_pop" href="#norrie.REF.walsh.2010.456">Walsh et al 2010</a>].</div></li></ul></li><li class="half_rhythm"><div>In the progressive stage of the Norrie disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, development of increased intraocular pressure may require surgery. Rarely, enucleation of the eye is required to control pain.</div></li></ul><p><b>Sensorineural hearing loss</b></p><ul><li class="half_rhythm"><div>Hearing aid augmentation is usually successful well into middle or late adulthood.</div></li><li class="half_rhythm"><div>Cochlear implantation should be considered when hearing-assisted audiologic function is significantly impaired.</div></li></ul><p><b>Behavioral issues</b> are a lifelong challenge to many individuals with Norrie disease and to their guardians/caretakers, whether or not intellectual disability or cognitive impairment is present. Intervention and therapy are supportive and aimed at maximizing educational opportunities.</p><p>An empiric trial of psychotropic medications may be warranted, although no studies have addressed or supported the use of specific medications for treatment of Norrie disease.</p></div><div id="norrie.Surveillance"><h3>Surveillance</h3><p>The following are recommended:</p><ul><li class="half_rhythm"><div>Routine follow up with an ophthalmologist in all individuals with an <i>NDP</i>-related retinopathy, even when vision is severely reduced</div></li><li class="half_rhythm"><div>Given that most individuals with the <i>NDP</i>-related spectrum of retinopathies are blind, routine monitoring of hearing so that hearing loss can be detected early and managed appropriately</div></li><li class="half_rhythm"><div>Observation for clinical evidence of venous stasis or ulcer disease</div></li></ul></div><div id="norrie.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Given the increased risk of hearing loss, exposure to loud noises should be avoided.</p></div><div id="norrie.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#norrie.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes</p></div><div id="norrie.Pregnancy_Management"><h3>Pregnancy Management</h3><p>A planned delivery at 34 weeks' gestation of a male with an established <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (in whom retinal detachment was excluded following fetal ultrasonography at 28 and 33 weeks) was reported [<a class="bk_pop" href="#norrie.REF.sisk.2014.1312">Sisk et al 2014</a>]. Authors describe treatment at two days of life with laser ablation of the avascular retina in both eyes and ten-month follow up that showed the retina to remain completely attached in both eyes [<a class="bk_pop" href="#norrie.REF.sisk.2014.1312">Sisk et al 2014</a>].</p></div><div id="norrie.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><a class="bk_pop" href="#norrie.REF.ohlmann.2005.1701">Ohlmann et al [2005]</a> have elaborated in the mouse knockout a failure of retinal angiogenesis and documented correction of the ocular-vascular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> by transgenic ectopic lens expression of norrin. These authors also noted a potential effect of norrin on retinal ganglion cell proliferation.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="norrie.Genetic_Counseling"><h2 id="_norrie_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="norrie.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>NDP</i>-related retinopathies are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="norrie.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is neither <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> nor a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</div></li><li class="half_rhythm"><div>The majority of mothers of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are carriers of an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, even when the family history is negative.</div></li><li class="half_rhythm"><div>Rarely, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Women who are carriers may have an inherited or <i>de novo</i> pathogenic variant.</div></li><li class="half_rhythm"><div>Women who have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child and one other affected relative are obligate heterozygotes (carriers).</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the pathogenic variant will be carriers and will generally not be affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified in DNA extracted from the mother's leukocytes, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Males with an <i>NDP</i>-related retinopathy will pass the <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of their daughters, who will be carriers, and to none of their sons.</p><p><b>Other family members of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The proband's maternal aunts may be at risk of being carriers of an <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring, depending on their gender, may be at risk of being carriers or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="norrie.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Identification of female carriers requires one of the following:</p><ul><li class="half_rhythm"><div>Prior identification of the <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family</div></li><li class="half_rhythm"><div>If an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, then by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> (see <a class="figpopup" href="/books/NBK1331/table/norrie.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="fignorrieTmoleculargenetictestingused" rid-ob="figobnorrieTmoleculargenetictestingused">Table 2</a>)</div></li><li class="half_rhythm"><div>Linkage analysis if:</div><ul><li class="half_rhythm"><div>Sequence analysis and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis do not identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>;</div><div>AND</div></li><li class="half_rhythm"><div>The family structure is appropriate for linkage studies;</div><div>AND</div></li><li class="half_rhythm"><div>The necessary family members are available for testing.</div></li></ul></li></ul><p>Note: Carriers are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder and rarely develop clinical findings related to the disorder; however, individuals with manifestations have been described [<a class="bk_pop" href="#norrie.REF.lin.2010.93">Lin et al 2010</a>, <a class="bk_pop" href="#norrie.REF.romaniello.2013.1702">Romaniello et al 2013</a>, <a class="bk_pop" href="#norrie.REF.parzefall.2014.203">Parzefall et al 2014</a>] and caution should be maintained when discussing <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> risk in the context of genetic and prenatal counseling.</p></div><div id="norrie.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="norrie.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for an <i>NDP</i>-related retinopathy are possible.</p></div></div><div id="norrie.Resources"><h2 id="_norrie_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=norriedisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Norrie disease</a></div></li><li class="half_rhythm"><div><b>Norrie Disease Association (NDA)</b></div><div>PO Box 3244</div><div>Munster IN 46321</div><div><b>Email:</b> joinnda@gmail.com</div><div><a href="http://www.norriedisease.org/home" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.norriedisease.org</a></div></li><li class="half_rhythm"><div><b>American Council of the Blind (ACB)</b></div><div>2200 Wilson Boulevard</div><div>Suite 650</div><div>Arlington VA 22201</div><div><b>Phone:</b> 800-424-8666 (toll-free); 202-467-5081</div><div><b>Fax:</b> 202-467-5085</div><div><b>Email:</b> info@acb.org</div><div><a href="http://www.acb.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.acb.org</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li><li class="half_rhythm"><div><b>National Federation of the Blind (NFB)</b></div><div>200 East Wells Street</div><div>(at Jernigan Place)</div><div>Baltimore MD 21230</div><div><b>Phone:</b> 410-659-9314</div><div><b>Fax:</b> 410-685-5653</div><div><b>Email:</b> pmaurer@nfb.org</div><div><a href="http://www.nfb.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfb.org</a></div></li><li class="half_rhythm"><div><b>Norrie Disease Registry</b></div><div>Massachusetts General Hospital</div><div>185 Cambridge Street</div><div>CRP Building North, 5th Floor, Suite 5300</div><div>Boston MA 02114</div><div><b>Phone:</b> 617-726-5718</div><div><b>Fax:</b> 617-724-9620</div><div><b>Email:</b> ksims@mgh.harvard.edu</div></li></ul></div><div id="norrie.Molecular_Genetics"><h2 id="_norrie_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="norrie.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>NDP-Related Retinopathies: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1331/table/norrie.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__norrie.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_norrie.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_norrie.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_norrie.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_norrie.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_norrie.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_norrie.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_norrie.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4693" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NDP</i></a></td><td headers="hd_b_norrie.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4693" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_norrie.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q00604" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Norrin</a></td><td headers="hd_b_norrie.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.retina-international.org/files/sci-news/ndgmut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the Norrie Disease Gene (NDP)</a><br /><a href="http://databases.lovd.nl/shared/genes/NDP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NDP database</a></td><td headers="hd_b_norrie.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NDP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NDP</a></td><td headers="hd_b_norrie.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NDP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NDP</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="norrie.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="norrie.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for NDP-Related Retinopathies (<a href="/omim/300216,300658,305390,310600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1331/table/norrie.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__norrie.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300216" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300216</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COATS DISEASE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300658" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300658</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NDP GENE; NDP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/305390" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">305390</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/310600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">310600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NORRIE DISEASE; ND</td></tr></tbody></table></div></div><div id="norrie.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Mouse model studies have documented that norrin deficiency plays a critical role in the retinal and cochlear vasculopathy [<a class="bk_pop" href="#norrie.REF.xu.2004.883">Xu et al 2004</a>, <a class="bk_pop" href="#norrie.REF.hendrickx.2008.229">Hendrickx &#x00026; Leyns 2008</a>] and presumably the same pathobiologic failure of normal angiogenesis underlies the visual failure and risk of hearing loss and/or intellectual disability in human ND. Studies in the knockout mouse (<i>Ndp y/-</i>) have shown failure of retinal angiogenesis with complete lack of the deep capillary layers of the retina and progressive loss of vessels in the stria vascularis of the cochlea [<a class="bk_pop" href="#norrie.REF.rehm.2002.4286">Rehm et al 2002</a>]. This failed retinal vascularization presumably leads to retinal hypoxia and fatal retinal injury [<a class="bk_pop" href="#norrie.REF.luhmann.2005.3372">Luhmann et al 2005</a>].</p><p>Norrin binds to the Fzd4 CRD [<a class="bk_pop" href="#norrie.REF.smallwood.2007.4057">Smallwood et al 2007</a>]. Norrin-Fzd4 signaling [<a class="bk_pop" href="#norrie.REF.ye.2010.417">Ye et al 2010</a>], with subsequent activation of the classic Wnt pathway, plays a central role in retinal vascular development [<a class="bk_pop" href="#norrie.REF.xu.2004.883">Xu et al 2004</a>, <a class="bk_pop" href="#norrie.REF.warden.2007.211">Warden et al 2007</a>, <a class="bk_pop" href="#norrie.REF.parmalee.2008.558">Parmalee &#x00026; Kitajewski 2008</a>, <a class="bk_pop" href="#norrie.REF.ohlmann.2012.243">Ohlmann &#x00026; Tamm 2012</a>] including effect on endothelial cell proliferation, migration and retinal invasion, arterial and venous topography, and stability of the BBB and BRB through regulation of transcription factors, cell surface receptors, and cell junction proteins [<a class="bk_pop" href="#norrie.REF.paes.2011.6452">Paes et al 2011</a>, <a class="bk_pop" href="#norrie.REF.wang.2012.1332">Wang et al 2012</a>]. Norrin also has significant neuroprotective properties through activation of Wnt/beta-catenin signaling [<a class="bk_pop" href="#norrie.REF.seitz.2010.5998">Seitz et al 2010</a>] and induction of neuroprotective growth factor synthesis in Muller cells [<a class="bk_pop" href="#norrie.REF.ohlmann.2012.243">Ohlmann &#x00026; Tamm 2012</a>]. Norrin is expressed widely in brain astrocytes and cerebellar Bergmann glia [<a class="bk_pop" href="#norrie.REF.ye.2011.151">Ye et al 2011</a>], suggesting an as-yet unclarified phenotypic role in these CNS systems.</p><p>The role that norrin plays in intellectual disability remains unclear. Recently, <i>NDP</i> expression was shown to be initiated in retinal progenitors in response to Hedgehog (Hh) signaling through induction of Gli2 binding to the <i>NDP</i> promoter [<a class="bk_pop" href="#norrie.REF.mcneill.2013.1005">McNeill et al 2013</a>]. The authors hypothesized a possible role for <i>Ndp</i> in more global neural function, given the identification of <i>Ndp</i> function in neural progenitor proliferation apart from its function in the retinal vasculature.</p><p><b>Gene structure.</b>
<i>NDP</i> spans 28 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. The <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises three exons, and the coding portion spans the latter half of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 and the first portion of exon 3 yielding a <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> of 2.1 kb. Exon 1 is untranslated and may function as a <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> for <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription. ND-associated pathogenic variants have been identified in exon 1 [<a class="bk_pop" href="#norrie.REF.schuback.1995.285">Schuback et al 1995</a>, <a class="bk_pop" href="#norrie.REF.kenyon.1999.181">Kenyon &#x00026; Craig 1999</a>], although their functional significance remains controversial. A cysteine-rich region, presumed critical to secondary protein structure, exists in the carboxyl terminus of exon 3. It is here that the majority of pathogenic variants have been identified, although such variants are widely dispersed throughout the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>. For a detailed summary of gene and protein information, see <a href="/books/NBK1331/#norrie.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> The possibility remains that single-nucleotide variants (SNVs) may play a role in ND clinical phenotypic expression or modulation. Both <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1, associated with advanced ROP, have been described [<a class="bk_pop" href="#norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</a>, <a class="bk_pop" href="#norrie.REF.dickinson.2006.682">Dickinson et al 2006</a>, <a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>]. Exon 1 insertions and deletions have been seen in a number of controls [Sims, unpublished data], suggesting that these may be benign. It remains, however, a possibility that these exon 1 variants predispose to a clinical vascular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in certain at-risk cohorts.</p><p><b>Pathogenic variants.</b> More than 100 <i>NDP</i> pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a>, splice, deletions) have been described [<a class="bk_pop" href="#norrie.REF.ye.2010.417">Ye et al 2010</a>]. The majority of pathogenic variants are single-base-pair changes identified in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of <i>NDP</i> [<a class="bk_pop" href="#norrie.REF.schuback.1995.285">Schuback et al 1995</a>, <a class="bk_pop" href="#norrie.REF.shastry.1998.35">Shastry 1998</a>, <a class="bk_pop" href="#norrie.REF.zaremba.1998.157">Zaremba et al 1998</a>, <a class="bk_pop" href="#norrie.REF.black.1999.2031">Black et al 1999</a>, <a class="bk_pop" href="#norrie.REF.hiraoka.2001b.53">Hiraoka et al 2001b</a>, <a class="bk_pop" href="#norrie.REF.yamada.2001.52">Yamada et al 2001</a>, <a class="bk_pop" href="#norrie.REF.dickinson.2006.682">Dickinson et al 2006</a>, <a class="bk_pop" href="#norrie.REF.drenser.2007.243">Drenser et al 2007</a>, <a class="bk_pop" href="#norrie.REF.kondo.2007.1276">Kondo et al 2007</a>, <a class="bk_pop" href="#norrie.REF.lev.2007.921">Lev et al 2007</a>, <a class="bk_pop" href="#norrie.REF.wu.2007.225">Wu et al 2007</a>, <a class="bk_pop" href="#norrie.REF.khan.2008.730">Khan et al 2008</a>, <a class="bk_pop" href="#norrie.REF.yang.2012.726">Yang et al 2012</a>].</p><p>More than 20 DNA rearrangements have been noted including intragenic (small) deletions, or submicroscopic (<i>"NDP</i> plus") deletions and account for approximately 15% of pathogenic variants [<a class="bk_pop" href="#norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</a>; <a class="bk_pop" href="#norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga et al 2007</a>; <a class="bk_pop" href="#norrie.REF.staropoli.2010.786">Staropoli et al 2010</a>; Sims, unpublished data]. Affected individuals with insertions [<a class="bk_pop" href="#norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</a>], complex rearrangements [<a class="bk_pop" href="#norrie.REF.schuback.1995.285">Schuback et al 1995</a>], and X;autosome translocations [<a class="bk_pop" href="#norrie.REF.meire.1998.203">Meire et al 1998</a>] have been documented. A few of these individuals have deletions that have been identified as extending beyond the <i>NDP</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>. These individuals have more complex phenotypes suggestive of contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> syndromes [<a class="bk_pop" href="#norrie.REF.sims.1989.1069">Sims et al 1989</a>, <a class="bk_pop" href="#norrie.REF.su_rezmerino.2001.523">Su&#x000e1;rez-Merino et al 2001</a>, <a class="bk_pop" href="#norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga et al 2007</a>, <a class="bk_pop" href="#norrie.REF.staropoli.2010.786">Staropoli et al 2010</a>].</p><p><a class="bk_pop" href="#norrie.REF.ke.2013.2305">Ke et al [2013]</a> characterized five categories of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> based on crystalline structure of <i>NDP</i>: (1) cysteine residue, (2) dimer interface, (3) hydrophobic core, (4) <i>Fzd4</i> binding site, and (5) <i>Lrp5/6</i> binding site variants. Fzd4 cysteine-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (CRD) variants had previously been shown to affect Norrin binding and signaling [<a class="bk_pop" href="#norrie.REF.zhang.2011.10210">Zhang et al 2011</a>].</p><p>Most pathogenic variants are unique and have been identified in single individuals/families; a few pathogenic variants have been seen in multiple, apparently unrelated families. Founder variants have not been identified. The pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants all predict significant amino acid change and often affect one of the many cysteine residues immediately adjacent to a cysteine. These cysteine residues are presumed important for the maintenance of protein structure, and pathogenic variants in these residues would be potentially deleterious to protein function.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Norrin [<a href="/nuccore/NM_000266" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000266</a>; <a href="/protein/NP_000257" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000257</a>] is a secreted protein comprising 133 amino acids; it has a cysteine-knot motif (highly conserved in many growth factors). Crystal structure analysis indicates that norrin exists as a homodimer and that dimer formation is required for binding to Frizzled-4 (Fzd4) receptors [<a class="bk_pop" href="#norrie.REF.ke.2013.2305">Ke et al 2013</a>]. This binding activates the canonical Wnt/beta-catenin signaling pathway and is enhanced by Tspan12 [<a class="bk_pop" href="#norrie.REF.junge.2009.299">Junge et al 2009</a>]. Norrin is critical in CNS vascular development as norrin is required for angiogenesis in the eye, ear, and brain; maintains the blood-brain-barrier (BBB) and the blood-retinal-barrier (BRB); and exhibits neuro-protective properties for retinal neurons.</p><p>Messenger RNA localization by in situ hybridization to the outer nuclear layer, inner nuclear layer, and ganglion cell layer of the retina (mice, rabbit, human) early on suggested a role in retinal development [<a class="bk_pop" href="#norrie.REF.hartzer.1999.355">Hartzer et al 1999</a>]. Later and ongoing animal model studies (see <b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>) have continued to support a role for norrin in cellular or tissue differentiation and maintenance of cellular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and in intercellular communication, critical to normal retinal, CNS, and cochlear development.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the norrin-deficient mouse models (<i>Ndp y/-</i>) shows impaired retinal vascular development with inadequate capillary outgrowth into the retinal surface and attendant loss of all intraretinal capillaries [<a class="bk_pop" href="#norrie.REF.richter.1998.2450">Richter et al 1998</a>, <a class="bk_pop" href="#norrie.REF.rehm.2002.4286">Rehm et al 2002</a>, <a class="bk_pop" href="#norrie.REF.luhmann.2005.3372">Luhmann et al 2005</a>, <a class="bk_pop" href="#norrie.REF.ohlmann.2005.1701">Ohlmann et al 2005</a>], as well as abnormal persistence of the hyaloid vasculature. Late-onset hearing loss was seen associated with cochlear degeneration [<a class="bk_pop" href="#norrie.REF.berger.1998.95">Berger 1998</a>], and abnormal vessels in the inner ear were described [<a class="bk_pop" href="#norrie.REF.rehm.2002.4286">Rehm et al 2002</a>, <a class="bk_pop" href="#norrie.REF.ohlmann.2005.1701">Ohlmann et al 2005</a>]. Differential gene expression in <i>Ndp</i> knockout mice provides further evidence of a role for norrin in retinal vascular development [<a class="bk_pop" href="#norrie.REF.sch_fer.2009.906">Sch&#x000e4;fer et al 2009</a>, <a class="bk_pop" href="#norrie.REF.ye.2011.151">Ye et al 2011</a>, <a class="bk_pop" href="#norrie.REF.lee.2013.447">Lee et al 2013</a>].</p><p>Exogenous norrin has been shown to restore the normal retinal vascular network [<a class="bk_pop" href="#norrie.REF.ohlmann.2005.1701">Ohlmann et al 2005</a>], suppress vascular loss and pathologic neovascularization in a mouse model of ROP [<a class="bk_pop" href="#norrie.REF.ohlmann.2010.183">Ohlmann et al 2010</a>], and rescue the retinal vasculature in a mouse model of oxygen-induced retinopathy [<a class="bk_pop" href="#norrie.REF.tokunaga.2013.222">Tokunaga et al 2013</a>]. Overexpression of norrin activates the Wnt/beta-catenin and endothelin-2 signaling and protects photoreceptors from light damage [<a class="bk_pop" href="#norrie.REF.braunger.2013.1">Braunger et al 2013</a>].</p></div></div><div id="norrie.References"><h2 id="_norrie_References_">References</h2><div id="norrie.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.allen.2006.234">Allen RC, Russell SR, Streb LM, Alsheikheh A, Stone EM. Phenotypic heterogeneity associated with a novel mutation (Gly112Glu) in the Norrie disease protein. <span><span class="ref-journal">Eye. </span>2006;<span class="ref-vol">20</span>:234–41.</span> [<a href="/pubmed/15776010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15776010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.anderson.2012.338">Anderson BH, Kasher PR, Mayer J, Szynkiewicz M, Jenkinson EM, Bhaskar SS, Urquhart JE, Daly SB, Dickerson JE, O'Sullivan J, Leibundgut EO, Muter J, Abdel-Salem GM, Babul-Hirji R, Baxter P, Berger A, Bonaf&#x000e9; L, Brunstom-Hernandez JE, Buckard JA, Chitayat D, Chong WK, Cordelli DM, Ferreira P, Fluss J, Forrest EH, Franzoni E, Garone C, Hammans SR, Houge G, Hughes I, Jacquemont S, Jeannet PY, Jefferson RJ, Kumar R, Kutschke G, Lundberg S, Louren&#x000e7;o CM, Mehta R, Naidu S, Nischal KK, Nunes L, Ounap K, Philippart M, Prabhakar P, Risen SR, Schiffmann R, Soh C, Stephenson JB, Stewart H, Stone J, Tolmie JL, van der Knaap MS, Vieira JP, Vilain CN, Wakeling EL, Wermenbol V, Whitney A, Lovell SC, Meyer S, Livingston JH, Baerlocher GM, Black GC, Rice GI, Crow YJ. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:338–42.</span> [<a href="/pubmed/22267198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22267198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.arai.2014.448">Arai E, Fujimaki T, Yanagawa A, Fujiki K, Yokoyama T, Okumura A, Shimizu T, Murakami A. Familial cases of Norrie disease detected by copy number analysis. <span><span class="ref-journal">Jpn J Ophthalmol. </span>2014;<span class="ref-vol">58</span>:448–54.</span> [<a href="/pubmed/25023092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25023092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.berger.1998.95">Berger W. Molecular dissection of Norrie disease. <span><span class="ref-journal">Acta Anat (Basel). </span>1998;<span class="ref-vol">162</span>:95–100.</span> [<a href="/pubmed/9831755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9831755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.berger.2001">Berger W, Ropers H-H. Norrie disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease.</em> 8 ed. New York, NY: McGraw-Hill; 2001:5977-85.</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.black.1999.2031">Black GC, Perveen R, Bonshek R, Cahill M, Clayton-Smith J, Lloyd IC, McLeod D. Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:2031–5.</span> [<a href="/pubmed/10484772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10484772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.braunger.2013.1">Braunger BM, Ohlmann A, Koch M, Tanimoto N, Volz C, Yang Y, Bosl MR, Cvekl A, Jagle H, Seeliger MW, Tamm ER. Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage. <span><span class="ref-journal">Neurobiol Dis. </span>2013;<span class="ref-vol">50</span>:1–12.</span> [<a href="/pubmed/23009755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23009755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.chow.2010.2402">Chow CC, Kiernan DF, Chau FY, Blair MP, Ticho BH, Galasso JM, Sahpiro MJ. Laser photocoagulation at birth prevents blindness in Norrie&#x02019;s disease diagnosed using amniocentesis. <span><span class="ref-journal">Ophthalmology. </span>2010;<span class="ref-vol">117</span>:2402–6.</span> [<a href="/pubmed/20619898" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20619898</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.dickinson.2006.682">Dickinson JL, Sale MM, Passmore A, Fitzgerald LM, Wheatley CM, Burdon KP, Craig JE, Tengtrisorn S, Carden SM, Maclean H, Mackey DA. Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. <span><span class="ref-journal">Clinical and Experimental Ophthalmology. </span>2006;<span class="ref-vol">34</span>:682–8.</span> [<a href="/pubmed/16970763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16970763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.drenser.2007.243">Drenser KA, Fecko A, Dailey W, Trese MT. A characteristic phenotypic retinal appearance in Norrie disease. <span><span class="ref-journal">Retina. </span>2007;<span class="ref-vol">27</span>:243–6.</span> [<a href="/pubmed/17290208" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17290208</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.haider.2002.365">Haider MZ, Devarajan LV, Al-Essa M, Kumar H. A C597--&#x0003e;A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants. <span><span class="ref-journal">J Biomed Sci. </span>2002;<span class="ref-vol">9</span>:365–70.</span> [<a href="/pubmed/12145535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12145535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.haider.2001.120">Haider MZ, Devarajan LV, Al-Essa M, Srivastva BS, Kumar H, Azad R, Rashwan N. Retinopathy of prematurity: mutations in the Norrie disease gene and the risk of progression to advanced stages. <span><span class="ref-journal">Pediatr Int. </span>2001;<span class="ref-vol">43</span>:120–3.</span> [<a href="/pubmed/11285060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11285060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.halpin.2005.533">Halpin C, Owen G, Gutierrez-Espeleta GA, Sims K, Rehm HL. Audiologic features of Norrie disease. <span><span class="ref-journal">Ann Otol Rhinol Laryngol. </span>2005;<span class="ref-vol">114</span>:533–8.</span> [<a href="/pubmed/16134349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16134349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.halpin.2008.1705">Halpin C, Sims K. Twenty years of audiology in a patient with Norrie disease. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2008;<span class="ref-vol">72</span>:1705–10.</span> [<a href="/pubmed/18817988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18817988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.hartzer.1999.355">Hartzer MK, Cheng M, Liu X, Shastry BS. Localization of the Norrie disease gene mRNA by in situ hybridization. <span><span class="ref-journal">Brain Res Bull. </span>1999;<span class="ref-vol">49</span>:355–8.</span> [<a href="/pubmed/10452356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10452356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.hendrickx.2008.229">Hendrickx M, Leyns L. Non-conventional Frizzled ligands and Wnt receptors. <span><span class="ref-journal">Dev Growth Differ. </span>2008;<span class="ref-vol">50</span>:229–43.</span> [<a href="/pubmed/18366384" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18366384</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.hiraoka.2001a.178">Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. <span><span class="ref-journal">J Hum Genet. </span>2001a;<span class="ref-vol">46</span>:178–81.</span> [<a href="/pubmed/11322656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11322656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.hiraoka.2001b.53">Hiraoka M, Rossi F, Trese MT, Shastry BS. X-linked juvenile retinoschisis: mutations at the retinoschisis and Norrie disease gene loci? <span><span class="ref-journal">J Hum Genet. </span>2001b;<span class="ref-vol">46</span>:53–6.</span> [<a href="/pubmed/11281412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11281412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.hiraoka.2010.2572">Hiraoka M, Takahashi H, Orimo H, Hiraoka M, Ogata T, Azuma N. Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity. <span><span class="ref-journal">Mol Vis. </span>2010;<span class="ref-vol">16</span>:2572–7.</span> [<a href="/pmc/articles/PMC3000231/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3000231</span></a>] [<a href="/pubmed/21151595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21151595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.hutcheson.2005.501">Hutcheson KA, Paluru PC, Bernstein SL, Koh J, Rappaport EF, Leach RA, Young TL. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. <span><span class="ref-journal">Mol Vis. </span>2005;<span class="ref-vol">11</span>:501–8.</span> [<a href="/pubmed/16052165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16052165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.jiao.2004.878">Jiao X, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF. Autosomal recessive familial exudative vitroretionopathy is aoiated with mutations in LRP5. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:878–84.</span> [<a href="/pmc/articles/PMC1182117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182117</span></a>] [<a href="/pubmed/15346351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15346351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.junge.2009.299">Junge HJ, Yng S, Burton JB, Paes K, Sh X, French DM, Costa M, Rice DS, Ye W. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. <span><span class="ref-journal">Cell. </span>2009;<span class="ref-vol">139</span>:299–311.</span> [<a href="/pubmed/19837033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19837033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.ke.2013.2305">Ke J, Harikumar KG, Erice C, Chen C, Gu X, Wang L, Parker N, Cheng Z, Xu W, Williams BO, Melcher K, Miller LJ, Xu HE. Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex. <span><span class="ref-journal">Genes Dev. </span>2013;<span class="ref-vol">27</span>:2305–19.</span> [<a href="/pmc/articles/PMC3828517/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3828517</span></a>] [<a href="/pubmed/24186977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24186977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.kenyon.1999.181">Kenyon JR, Craig IW. Analysis of the 5' regulatory region of the human Norrie's disease gene: evidence that a non-translated CT dinucleotide repeat in exon one has a role in controlling expression. <span><span class="ref-journal">Gene. </span>1999;<span class="ref-vol">227</span>:181–8.</span> [<a href="/pubmed/10023053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10023053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.khan.2008.730">Khan AO, Aldahmesh MA, Meyer B. Correlation of ophthalmic examination in carrier status in females potentially harboring a severe Norrie disease gene mutations. <span><span class="ref-journal">Ophthalmology. </span>2008;<span class="ref-vol">115</span>:730–3.</span> [<a href="/pubmed/18387409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18387409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.khan.2004.361">Khan AO, Shamsi FA, Al-Saif A, Kambouris M. A novel missense Norrie disease mutation associated with a severe ocular phenotype. <span><span class="ref-journal">J Pediatr Ophthalmol Strabismus. </span>2004;<span class="ref-vol">41</span>:361–3.</span> [<a href="/pubmed/15609522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15609522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.kondo.2007.1276">Kondo H, Qin M, Kusaka S, Tahira T, Hasebe H, Hayashi H, Uchio E, Hayashi K. Novel mutations in Norrie disease gene in Japanese patients with Norrie disease and familial exudative vitreoretinopathy. <span><span class="ref-journal">Invest. Ophthalmol. Vis. Sci. </span>2007;<span class="ref-vol">48</span>:1276–82.</span> [<a href="/pubmed/17325173" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17325173</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.lee.2013.447">Lee H, Jo DH, Kim JH, Kim JH. Norrin expression in endothelial cells in the developing mouse retina. <span><span class="ref-journal">Acta Histochem. </span>2013;<span class="ref-vol">115</span>:447–51.</span> [<a href="/pubmed/23206555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23206555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.lenzner.2002.2825">Lenzner S, Prietz S, Feil S, Nuber UA, Ropers H-H, Berger W. Global gene expression analysis in a mouse model for Norrie disease: late involvement of photoreceptor cells. <span><span class="ref-journal">Invest. Ophthalmol. Vis. Sci. </span>2002;<span class="ref-vol">43</span>:2825–33.</span> [<a href="/pubmed/12202498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12202498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.lev.2007.921">Lev D, Weigl Y, Hasan M, Gak E, Davidovich M, Vinkler C, Leshinsky-Silver E, Lerman-Sagie T, Watemberg N. A novel missense mutation in the NDP gene in a child with Norrie disease and severe neurological involvement including infantile spasms. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:921–4.</span> [<a href="/pubmed/17334993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17334993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.lin.2010.93">Lin P, Shankar SP, Duncan J, Slavotinek A, Stone EM, Rutar T. Retinal vascular abnormalities and dragged maculae in a carrier with a new NDP mutation (c.268delC) that caused severe Norrie disease in the proband. <span><span class="ref-journal">J AAPOS. </span>2010;<span class="ref-vol">14</span>:93–6.</span> [<a href="/pubmed/20227630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20227630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.liu.2010.2653">Liu D, Hu Z, Peng Y, Yu C, Liu Y, Mo X, Li X, Lu L, Xu X, Su W, Pan Q, Xia K. A novel nonsense mutation in the <em>NDP</em> gene in a Chinese family with Norrie disease. <span><span class="ref-journal">Mol Vis. </span>2010;<span class="ref-vol">16</span>:2653–8.</span> [<a href="/pmc/articles/PMC3002970/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3002970</span></a>] [<a href="/pubmed/21179243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21179243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.luhmann.2005.3372">Luhmann UF, Lin J, Acar N, Lammel S, Feil S, Grimm C, Seeliger MW, Hammes HP, Berger W. Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:3372–82.</span> [<a href="/pubmed/16123442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16123442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.luhmann.2008.2619">Luhmann UFO, Neidhardt J, Kloeckener-Gruissem B, Sch&#x000e4;fer NF, Glaus E, Feil S, Berger W. Vascular changes in the cerebellum of Norrin/Ndph knockout mice correlate with high expression of Norrin and Frizzled-4. <span><span class="ref-journal">Eur. J Neurosci. </span>2008;<span class="ref-vol">27</span>:2619–28.</span> [<a href="/pubmed/18547247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18547247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.mcneill.2013.1005">McNeill B, Mazerolle C, Bassett EA, Mears AJ, Ringuette R, Lagali P, Picketts DJ, Paes K, Rice D, Wallace VA. Nedgehog regulates Norrie disease protein to drive neural progenitor self-renewal. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:1005–16.</span> [<a href="/pubmed/23201751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23201751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.meire.1998.203">Meire FM, Lafaut BA, Speleman F, Hanssens M. Isolated Norrie disease in a female caused by a balanced translocation t(X,6). <span><span class="ref-journal">Ophthalmic Genet. </span>1998;<span class="ref-vol">19</span>:203–7.</span> [<a href="/pubmed/9895245" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9895245</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.nikopoulos.2010a.240">Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE, Boonstra FN, Blokland EA, Arts P, Wieskamp N, Strom TM, Ayuso C, Tilanus MA, Bouwhuis S, Mukhopadhyay A, Scheffer H, Hoefsloot LH, Veltman JA, Cremers FP, Collin RW. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2010a;<span class="ref-vol">86</span>:240–7.</span> [<a href="/pmc/articles/PMC2820179/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2820179</span></a>] [<a href="/pubmed/20159111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.nikopoulos.2010b.656">Nikopoulos K, Venselaar H, Collin RW, Riveiro-Alvarez R, Boonstra FN, Hooymans JM, Mukhopadhyay A, Shears D, van Bers M, de Wijs IJ, van Essen AJ, Sijmons RH, Tilanus MA, van Nouhuys CE, Ayuso C, Hoefsloot LH, Cremers FP. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. <span><span class="ref-journal">Hum Mutat. </span>2010b;<span class="ref-vol">31</span>:656–66.</span> [<a href="/pubmed/20340138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20340138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.ohlmann.2005.1701">Ohlmann A, Scholz M, Goldwich A, Chauhan BK, Hudl K, Ohlmann AV, Zrenner E, Berger W, Cvekl A, Seeliger MW, Tamm ER. Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice. <span><span class="ref-journal">J Neurosci. </span>2005;<span class="ref-vol">25</span>:1701–10.</span> [<a href="/pmc/articles/PMC6725931/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6725931</span></a>] [<a href="/pubmed/15716406" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15716406</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.ohlmann.2010.183">Ohlmann A, Seitz R, Braunger B, Seitz D, B&#x000f6;sl MR, Tamm ER. Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice. <span><span class="ref-journal">J Neurosci. </span>2010;<span class="ref-vol">30</span>:183–93.</span> [<a href="/pmc/articles/PMC6632540/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6632540</span></a>] [<a href="/pubmed/20053900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20053900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.ohlmann.2012.243">Ohlmann A, Tamm ER. Norrin: molecular and functional properties of an angiogenic and neuroprotective growth factor. <span><span class="ref-journal">Prog Retin Eye Res. </span>2012;<span class="ref-vol">31</span>:243–57.</span> [<a href="/pubmed/22387751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22387751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.paes.2011.6452">Paes KT, Wang E, Henze K, Vogel P, Read R, Suwanichkul A, Kirkpatrick LL, Potter D, Newhouse MM, Rice DS. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2011;<span class="ref-vol">52</span>:6452–61.</span> [<a href="/pubmed/21743011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21743011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.parmalee.2008.558">Parmalee NL, Kitajewski J. Wnt signaling in angiogenesis. <span><span class="ref-journal">Current Drug Targets. </span>2008;<span class="ref-vol">9</span>:558–64.</span> [<a href="/pmc/articles/PMC4052372/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4052372</span></a>] [<a href="/pubmed/18673241" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18673241</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.parzefall.2014.203">Parzefall T, Lucas T, Ritter M, Ludwig M, Ramsebner R, Frohne A, Schofer C, Hengstschlager M, Frei K. A novel missense NDP mutation [p.(Cys93Arg)] with a manifesting carrier in an Austrian family with Norrie disease. <span><span class="ref-journal">Audiol Neurootol. </span>2014;<span class="ref-vol">19</span>:203–9.</span> [<a href="/pubmed/24801666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24801666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.polvi.2012.540">Polvi A, Linnankivi T, Kivel&#x000e4; T, Herva R, Keating JP, M&#x000e4;kitie O, Pareyson D, Vainionp&#x000e4;&#x000e4; L, Lahtinen J, Hovatta I, Pihko H, Lehesjoki AE. Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:540–9.</span> [<a href="/pmc/articles/PMC3309194/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3309194</span></a>] [<a href="/pubmed/22387016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22387016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.poulter.2010.248">Poulter JA, Ali M, Gilmour DF, Rice A, Kondo H, Hayashi K, Mackey DA, Kearns LS, Ruddle JB, Craig JE, Pierce EA, Downey LM, Mohamed MD, Markham AF, Inglehearn CF, Toomes C. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:248–53.</span> [<a href="/pmc/articles/PMC2820188/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2820188</span></a>] [<a href="/pubmed/20159112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20159112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.rehm.2002.4286">Rehm HL, Zhang DS, Brown MC, Burgess B, Halpin C, Berger W, Morton CC, Corey DP, Chen ZY. Vascular defects and sensorineural deafness in a mouse model of Norrie disease. <span><span class="ref-journal">J Neurosci. </span>2002;<span class="ref-vol">22</span>:4286–92.</span> [<a href="/pmc/articles/PMC6758776/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6758776</span></a>] [<a href="/pubmed/12040033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12040033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.richter.1998.2450">Richter M, Gottanka J, May CA, Welge-Lussen U, Berger W, Lutjen-Drecoll E. Retinal vasculature changes in Norrie disease mice. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>1998;<span class="ref-vol">39</span>:2450–7.</span> [<a href="/pubmed/9804153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9804153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.riveiroalvarez.2005.705">Riveiro-Alvarez R, Trujillo-Tiebas MJ, Gimenez-Pardo A, Garcia-Hoyos M, Cantalapiedra D, Lorda-Sanchez I, Rodriguez de Alba M, Ramos C, Ayuso C. Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR. <span><span class="ref-journal">Mol Vis. </span>2005;<span class="ref-vol">11</span>:705–12.</span> [<a href="/pubmed/16163268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16163268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.robitaille.2002.326">Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dube MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng B, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP, Samuels ME. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">32</span>:326–30.</span> [<a href="/pubmed/12172548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12172548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga L, Madrigal I, Alkhalidi LS, Armengol L, Gonzalex E, Badenas C, Estivill X, Mila M. Contiguous deletion of the NDP, MAOA, MAOBV and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:916–20.</span> [<a href="/pubmed/17431911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17431911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.romaniello.2013.1702">Romaniello R, Arrigoni F, Citterio A, Tonelli A, Sforzini C, Rizzari C, Pessina M, Triulzi F, Bassi MT, Borgatti R. Cerebroretinal microangiopathy with calcifications and cysts associated with <em>CTCI</em> and <em>NDP</em> mutaitons. <span><span class="ref-journal">J Child Neurol. </span>2013;<span class="ref-vol">28</span>:1702–8.</span> [<a href="/pubmed/23220793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23220793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.sch_fer.2009.906">Sch&#x000e4;fer NF, Luhmann UFO, Feil S, Berger W. Differential gene expression in Ndph-knockout mice in retinal development. <span><span class="ref-journal">Invest. Ophthalmol. Vis. Sci. </span>2009;<span class="ref-vol">50</span>:906–16.</span> [<a href="/pubmed/18978344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18978344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.schuback.1995.285">Schuback DE, Chen ZY, Craig IW, Breakefield XO, Sims KB. Mutations in the Norrie disease gene. <span><span class="ref-journal">Hum Mutat. </span>1995;<span class="ref-vol">5</span>:285–92.</span> [<a href="/pubmed/7627181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7627181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.seitz.2010.5998">Seitz R, Hackl S, Seibuchner T, Tamm ER, Ohlmann A. Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. <span><span class="ref-journal">J Neurosci. </span>2010;<span class="ref-vol">30</span>:5998–6010.</span> [<a href="/pmc/articles/PMC6632606/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6632606</span></a>] [<a href="/pubmed/20427659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20427659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.shastry.2000.627">Shastry BS, Hiraoka M, Trese MT. Lack of association of the Norrie disease gene with retinoschisis phenotype. <span><span class="ref-journal">Jpn J Ophthalmol. </span>2000;<span class="ref-vol">44</span>:627–9.</span> [<a href="/pubmed/11094177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11094177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.shastry.1997.651">Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. <span><span class="ref-journal">Arch Ophthalmol. </span>1997;<span class="ref-vol">115</span>:651–5.</span> [<a href="/pubmed/9152134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9152134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.shastry.1998.35">Shastry BS. Identification of a recurrent missense mutation in the Norrie disease gene associated with a simplex case of exudative vitreoretinopathy. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1998;<span class="ref-vol">246</span>:35–8.</span> [<a href="/pubmed/9618247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9618247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.shastry.2009a.884">Shastry BS. Persistent hyperplastic primary vitreous: congenital malformation of the eye. <span><span class="ref-journal">Clin Experiment Ophthalmol. </span>2009a;<span class="ref-vol">37</span>:884–90.</span> [<a href="/pubmed/20092598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20092598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.shastry.2009b.3">Shastry BS. SNPs: impact on gene function and phenotype. <span><span class="ref-journal">Methods Mol Biol. </span>2009b;<span class="ref-vol">578</span>:3–22.</span> [<a href="/pubmed/19768584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19768584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.sims.1989.1069">Sims KB, de la Chapelle A, Norio R, Sankila EM, Hsu YP, Rinehart WB, Corey TJ, Ozelius L, Powell JF, Bruns G, Gusella JF, Murphy DL, Breakefield XO. Monoamine oxidase deficiency in males with an X chromosome deletion. <span><span class="ref-journal">Neuron. </span>1989;<span class="ref-vol">2</span>:1069–76.</span> [<a href="/pubmed/2483108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2483108</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.sisk.2014.1312">Sisk RA, Hufnagel RB, Bandi S, Polzin WJ, Ahmed ZM. Planned Preterm Delivery and Treament of retinal neovascularization in Norrie disease. <span><span class="ref-journal">Ophthalmology. </span>2014;<span class="ref-vol">121</span>:1312–3.</span> [<a href="/pubmed/24529712" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24529712</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.smallwood.2007.4057">Smallwood PM, Williams J, Xu Q, Leahy DJ, Nathans J. Mutational analysis of Norrin-Frizzled4 recognition. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:4057–68.</span> [<a href="/pubmed/17158104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17158104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.smith.2012.1909">Smith SE, Mullen TE, Graham D, Sims KB, Rehm HL. Norrie disease: extraocular clinical manifestations in 56 patients. <span><span class="ref-journal">Am J Med Genet. </span>2012;<span class="ref-vol">158A</span>:1909–17.</span> [<a href="/pubmed/22786811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22786811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.staropoli.2010.786">Staropoli JF, Xin W, Sims KB. Co-segregation of Norrie disease and idiopathic pulmonary hypertension in a family with a microdeletion of the NDP region at Xp11.3-p11.4. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:786–90.</span> [<a href="/pubmed/20679667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20679667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.su_rezmerino.2001.523">Su&#x000e1;rez-Merino B, Bye J, McDowall J, Ross M, Craig IW. Sequence analysis and transcript identification within 1.5 mB of DNA deleted together with the NDP and MAO genes in atypical Norrie disease patients presenting with a profound phenotype. <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">17</span>:523.</span> [<a href="/pubmed/11385715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11385715</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.talks.2001.e46">Talks SJ, Ebenezer N, Hykin P, Adams G, Yang F, Schulenberg E, Gregory-Evans K, Gregory-Evans CY. De novo mutations in the 5' regulatory region of the Norrie disease gene in retinopathy of prematurity. <span><span class="ref-journal">J Med Genet. </span>2001;<span class="ref-vol">38</span>:E46.</span> [<a href="/pmc/articles/PMC1734786/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734786</span></a>] [<a href="/pubmed/11748312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11748312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.tokunaga.2013.222">Tokunaga CC, Chen Y-H, Dailey W, Cheng M, Drenser KA. Retinal vascular rescue of oxygen-induced retionopathy in mice by Norrin. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2013;<span class="ref-vol">54</span>:222–9.</span> [<a href="/pubmed/23188723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23188723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.toomes.2004.721">Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang Z, Trembath R, Woodruff G, Gregory-Evans CY, Gregory-Evans K, Parker MJ, Black GC, Downey LM, Zhang K, Inglehearn CF. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:721–30.</span> [<a href="/pmc/articles/PMC1181948/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181948</span></a>] [<a href="/pubmed/15024691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15024691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.walsh.2010.456">Walsh MK, Drenser KA, Capone A Jr, Trese MT. Early vitrectomy effective for Norrie disease. <span><span class="ref-journal">Arch Ophthalmol. </span>2010;<span class="ref-vol">128</span>:456–60.</span> [<a href="/pubmed/20385941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20385941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.walsh.2011.819">Walsh MK, Drenser KA, Capone A Jr, Trese MT. Norrie disease vs familial exudative vitreoretinopathy. <span><span class="ref-journal">Arch Ophthalmol. </span>2011;<span class="ref-vol">129</span>:819–20.</span> [<a href="/pubmed/21670366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21670366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.wang.2012.1332">Wang Y, Rattner A, Zhou Y, Williams J, Smallwood PM, Nathans J. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. <span><span class="ref-journal">Cell. </span>2012;<span class="ref-vol">151</span>:1332–44.</span> [<a href="/pmc/articles/PMC3535266/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3535266</span></a>] [<a href="/pubmed/23217714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23217714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.warden.2007.211">Warden SM, Andreoli CM, Mukai S. The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease. <span><span class="ref-journal">Semin Ophthalmol. </span>2007;<span class="ref-vol">22</span>:211–7.</span> [<a href="/pubmed/18097984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18097984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.wu.2007.225">Wu W-C, Drenser K, Trese M, Capone A Jr, Dailey W. Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. <span><span class="ref-journal">Arch Ophthalmol. </span>2007;<span class="ref-vol">125</span>:225–30.</span> [<a href="/pubmed/17296899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17296899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.xu.2004.883">Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, Nathans J. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. <span><span class="ref-journal">Cell. </span>2004;<span class="ref-vol">116</span>:883–95.</span> [<a href="/pubmed/15035989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15035989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.yamada.2001.52">Yamada K, Limprasert P, Ratanasukon M, Tengtrisorn S, Yingchareonpukdee J, Vasiknanonte P, Kitaoka T, Ghadami M, Niikawa N, Kishino T. Two Thai families with Norrie disease (ND): association of two novel missense mutations with severe ND phenotype, seizures, and a manifesting carrier. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">100</span>:52–5.</span> [<a href="/pubmed/11337749" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11337749</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.yang.2012.726">Yang H, Li S, Xiao X, Guo X, Zhange Q. Screening for DNP mutations in 44 unrelated pateints with familial exudative vitreoretinopathy or Norrie disease. <span><span class="ref-journal">Curr Eye Res. </span>2012;<span class="ref-vol">37</span>:726–9.</span> [<a href="/pubmed/22563645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22563645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.yang.2011.1128">Yang H, Xiao X, Li S, Mai G, Zhange Q. Novel <em>TSPAN12</em> mutations in patients with familial exudative vitroretionopathy and their associated phenotypes. <span><span class="ref-journal">Mol Vis. </span>2011;<span class="ref-vol">17</span>:1128–35.</span> [<a href="/pmc/articles/PMC3087453/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3087453</span></a>] [<a href="/pubmed/21552475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21552475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.ye.2011.151">Ye X, Smallwood P, Nathans J. Expression of the Norrie disease gene (<em>Ndp</em>) in developing and adult mouse eye, ear, and brain. <span><span class="ref-journal">Gene Expr Patterns. </span>2011;<span class="ref-vol">11</span>:151–5.</span> [<a href="/pmc/articles/PMC3061303/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3061303</span></a>] [<a href="/pubmed/21055480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21055480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.ye.2010.417">Ye X, Wang Y, Nathans J. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. <span><span class="ref-journal">Trends Mol Med. </span>2010;<span class="ref-vol">16</span>:417–25.</span> [<a href="/pmc/articles/PMC2963063/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2963063</span></a>] [<a href="/pubmed/20688566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20688566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.zaremba.1998.157">Zaremba J, Feil S, Juszko J, Myga W, van Duijnhoven G, Berger W. Intrafamilial variability of the ocular phenotype in a Polish family with a missense mutation (A63D) in the Norrie disease gene. <span><span class="ref-journal">Ophthalmic Genet. </span>1998;<span class="ref-vol">19</span>:157–64.</span> [<a href="/pubmed/9810571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9810571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.zhang.2011.10210">Zhang K, Harada Y, Wei X, Shukla D, Rajendran A, Tawansy K, Bedell M, Lim S, Shaw PX, He X, Yang Z. An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:10210–5.</span> [<a href="/pmc/articles/PMC3060474/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3060474</span></a>] [<a href="/pubmed/21177847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21177847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="norrie.REF.zhang.2013.739">Zhang XY, Jiang WY, Chen LM, Chen SQ. A novel Norrie disease pseudoglioma gene mutation, c.-1_2delAAT, responsible for Norrie disease in a Chinese family. <span><span class="ref-journal">Int J Ophthalmol. </span>2013;<span class="ref-vol">6</span>:739–43.</span> [<a href="/pmc/articles/PMC3874509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3874509</span></a>] [<a href="/pubmed/24392318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24392318</span></a>]</div></li></ul></div></div><div id="norrie.Chapter_Notes"><h2 id="_norrie_Chapter_Notes_">Chapter Notes</h2><div id="norrie.Author_Notes"><h3>Author Notes</h3><p>Web: <a href="http://www.dnalab.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.DNAlab.org</a></p></div><div id="norrie.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 September 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 July 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 August 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 May 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 June 2002 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 July 1999 (me) Review posted live</div></li><li class="half_rhythm"><div>10 February 1999 (ks) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1331</span><span class="label">PMID: <a href="/pubmed/20301506" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301506</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/myotonic-d2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/nfia-dis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1331&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1331/?report=reader">PubReader</a></li><li><a href="/books/NBK1331/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1331" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1331" style="display:none" title="Cite this Page"><div class="bk_tt">Sims KB. NDP-Related Retinopathies. 1999 Jul 30 [Updated 2014 Sep 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1331/pdf/Bookshelf_NBK1331.pdf">PDF version of this page</a> (536K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#norrie.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#norrie.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#norrie.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#norrie.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#norrie.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#norrie.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#norrie.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#norrie.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#norrie.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#norrie.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#norrie.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#norrie.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4693[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NDP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1488398" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1488398" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1488398" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1488398" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28602015" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and genetic analysis of Indian patients with NDP-related retinopathies.</a><span class="source">[Int Ophthalmol. 2018]</span><div class="brieflinkpop offscreen_noflow">Clinical and genetic analysis of Indian patients with NDP-related retinopathies.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sudha D, Ganapathy A, Mohan P, Mannan AU, Krishna S, Neriyanuri S, Swaminathan M, Rishi P, Chidambaram S, Arunachalam JP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int Ophthalmol. 2018 Jun; 38(3):1251-1260. Epub 2017 Jun 10.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16970763" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.</a><span class="source">[Clin Exp Ophthalmol. 2006]</span><div class="brieflinkpop offscreen_noflow">Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dickinson JL, Sale MM, Passmore A, FitzGerald LM, Wheatley CM, Burdon KP, Craig JE, Tengtrisorn S, Carden SM, Maclean H, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Exp Ophthalmol. 2006 Sep-Oct; 34(7):682-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16163268" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR.</a><span class="source">[Mol Vis. 2005]</span><div class="brieflinkpop offscreen_noflow">Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Riveiro-Alvarez R, Trujillo-Tiebas MJ, Gimenez-Pardo A, Garcia-Hoyos M, Cantalapiedra D, Lorda-Sanchez I, Rodriguez de Alba M, Ramos C, Ayuso C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Vis. 2005 Sep 2; 11:705-12. Epub 2005 Sep 2.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301506" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301506" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0419b975f66d18aa9fed82">NDP-Related Retinopathies - GeneReviews®</a><div class="ralinkpop offscreen_noflow">NDP-Related Retinopathies - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:23:53-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CFC25E04138D100000000028A00EC&amp;ncbi_session=CE8CFC25E0419B81_0650SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1331%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1331&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1331/&amp;ncbi_pagename=NDP-Related Retinopathies - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CFC25E0419B81_0650SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>